Current and future clinical applications for optical imaging of cancer: From intraoperative surgical guidance to cancer screening

Seminars in Oncology

Volumn 38, Issue 1, 2011, Pages 109-118

  Hadjipanayis, Costas G ^a,b   Jiang, Huabei ^c   Roberts, David W ^d   Yang, Lily ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; CY5.5 DYE; FLUORESCENT DYE; FLUOROCHROME; INDOCYANINE GREEN; IRDYE 800CW; IRON OXIDE; LIGAND; MAGNETIC IRON OXIDE NANOPARTICLE; MALEIMIDE; N HYDROXYSUCCINIMIDE; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLADDER TUMOR; BRAIN TUMOR; BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SCREENING; CANCER SURGERY; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED OPTICAL IMAGING; CONTRAST ENHANCEMENT; CYSTOSCOPY; DIFFUSE OPTICAL TOMOGRAPHY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; ESOPHAGUS TUMOR; FLUORESCENCE IMAGING; GLIOBLASTOMA; HUMAN; IMMUNOGENICITY; INTRAOPERATIVE PERIOD; MAMMOGRAPHY; MOLECULAR IMAGING; MULTICENTER STUDY (TOPIC); NEAR INFRARED SPECTROSCOPY; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATING ROOM; OPTICAL INSTRUMENTATION; OPTICAL TOMOGRAPHY; OPTICS; OVARY TUMOR; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; SKIN TUMOR; STOMACH TUMOR; SURGEON; SURGICAL ANATOMY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TUMOR; TUMOR CELL; TUMOR VOLUME; ULTRASOUND; X RAY MAMMOGRAPHY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORESCENT DYES; HUMANS; MOLECULAR IMAGING; MOLECULAR PROBES; NANOPARTICLES; NEOPLASMS; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, OPTICAL;

EID: 79952143495     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.11.008     Document Type: Article

References (78)

1. V. Ntziachristos, and B. Chance Probing physiology and molecular function using optical imaging: applications to breast cancer Breast Cancer Res 3 2001 41 46 (Pubitemid 32223652)
2. Z. Yuan, Z. Wang, R. Pan, J. Liu, H. Cohen, and Y. Pan High-resolution imaging diagnosis and staging of bladder cancer: comparison between optical coherence tomography and high-frequency ultrasound J Biomed Opt 13 2008 054007
3. S.S. You, Y.X. Jiang, and Q.L. Zhu US-guided diffused optical tomography: a promising functional imaging technique in breast lesions Eur Radiol 20 2010 309 317
4. H. Jiang, N.V. Iftimia, Y. Xu, J.A. Eggert, L.L. Fajardo, and K.L. Klove Near-infrared optical imaging of the breast with model-based reconstruction Acad Radiol 9 2002 186 194 (Pubitemid 34184167)
5. E.I. Galanzha, E.V. Shashkov, P.M. Spring, J.Y. Suen, and V.P. Zharov In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser Cancer Res 69 2009 7926 7934
6. M. Rajadhyaksha, M. Grossman, D. Esterowitz, R.H. Webb, and R.R. Anderson In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast J Invest Dermatol 104 1995 946 952
7. E.G. Van Meir, C.G. Hadjipanayis, A.D. Norden, H.K. Shu, P.Y. Wen, and J.J. Olson Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma CA Cancer J Clin 60 2010 166 193
8. M. Lacroix, D. Abi-Said, and D.R. Fourney A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 2001 190 198 (Pubitemid 32799739)
9. N. Sanai, and M.S. Berger Glioma extent of resection and its impact on patient outcome Neurosurgery 62 2008 753 764
10. U. Pichlmeier, A. Bink, G. Schackert, and W. Stummer Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients Neuro Oncol 10 2008 1025 1034
11. W. Stummer, U. Pichlmeier, and T. Meinel Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 2006 392 401
12. M.J. Van den Bent, R. Stupp, W. Mason, R.O. Mirimanoff, D. Lacombe, and T. Gorlia Impact of the extent of resection on overall survival in newly-diagnosed glioblastoma after chemo-irradiation with temozolamide: further analysis of EORTC study 26981 [abstract] Eur J Cancer Suppl 3 2005 134
13. J.C. Tonn, and W. Stummer Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls Clin Neurosurg 55 2008 20 26
14. W. Stummer, H.J. Reulen, and T. Meinel Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias Neurosurgery 62 2008 564 576
15. W. Zheng, M. Olivo, and K.C. Soo The use of digitized endoscopic imaging of 5-ALA-induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo Int J Cancer 110 2004 295 300 (Pubitemid 38580406)
16. S.R. Millon, J.H. Ostrander, and S. Yazdanfar Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes J Biomed Opt 15 2010 018002
17. K. Svanberg, I. Wang, and S. Colleen Clinical multi-colour fluorescence imaging of malignant tumoursinitial experience Acta Radiol 39 1998 2 9 (Pubitemid 128459352)
18. Roberts DW, Valdes PA, Harris BT, et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. J Neurosurg April 9. (Epub ahead of print).
19. P. Mlkvy, H. Messmann, and J. Regula Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX) A pilot study Neoplasma 42 1995 109 113
20. D.I. Daniltchenko, C.R. Riedl, and M.D. Sachs Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study J Urol 174 2005 2129 2133 (Pubitemid 41611752)
21. K.D. Sievert, and S. Kruck Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer Expert Rev Anticancer Ther 9 2009 1055 1063
22. K.D. Sievert, B. Amend, and U. Nagele Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27 2009 295 300
23. M. Burger, D. Zaak, and C.G. Stief Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis Eur Urol 52 2007 142 147 (Pubitemid 46803019)
24. S. Denzinger, W.F. Wieland, W. Otto, T. Filbeck, R. Knuechel, and M. Burger Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study BJU Int 101 2008 566 569 (Pubitemid 351199276)
25. S. Denzinger, M. Burger, and B. Walter Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study Urology 69 2007 675 679 (Pubitemid 46574917)
26. D.J. Hawrysz, and E.M. Sevick-Muraca Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents Neoplasia 2 2000 388 417 (Pubitemid 32044786)
27. H. Jiang, S. Ramesh, and M. Bartlett Combined optical and fluorescence imaging for breast cancer detection and diagnosis Crit Rev Biomed Eng 28 2000 371 375 (Pubitemid 32871366)
28. M. Ogawa, N. Kosaka, P.L. Choyke, and H. Kobayashi In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green Cancer Res 69 2009 1268 1272
29. A. Becker, C. Hessenius, and K. Licha Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands Nat Biotechnol 19 2001 327 331 (Pubitemid 32275340)
30. E.M. Sevick-Muraca, R. Sharma, and J.C. Rasmussen Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study Radiology 246 2008 734 741
31. R.A. McLaughlin, L. Scolaro, P. Robbins, S. Hamza, C. Saunders, and D.D. Sampson Imaging of human lymph nodes using optical coherence tomography: potential for staging cancer Cancer Res 70 2010 2579 2584
32. A. Liebert, H. Wabnitz, and H. Obrig Non-invasive detection of fluorescence from exogenous chromophores in the adult human brain Neuroimage 31 2006 600 608 (Pubitemid 43776652)
33. S.L. Troyan, V. Kianzad, and S.L. Gibbs-Strauss The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping Ann Surg Oncol 16 2009 2943 2952
34. E.M. Sevick-Muraca, and J.C. Rasmussen Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine J Biomed Opt 13 2008 041303
35. A. de Boer, C. Kluft, and J.M. Kroon Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator Thromb Haemost 67 1992 83 87
36. M. Gurfinkel, A.B. Thompson, and W. Ralston Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study Photochem Photobiol 72 2000 94 102
37. X. Intes, J. Ripoll, Y. Chen, S. Nioka, A.G. Yodh, and B. Chance In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green Med Phys 30 2003 1039 1047 (Pubitemid 36735969)
38. K. Licha, B. Riefke, V. Ntziachristos, A. Becker, B. Chance, and W. Semmler Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization Photochem Photobiol 72 2000 392 398
39. S. Yoneya, T. Saito, Y. Komatsu, I. Koyama, K. Takahashi, and J. Duvoll-Young Binding properties of indocyanine green in human blood Invest Ophthalmol Vis Sci 39 1998 1286 1290 (Pubitemid 28247368)
40. S. Keiding, P. Ott, and L. Bass Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures J Hepatol 19 1993 327 344 (Pubitemid 24029909)
41. P.A. Carney, D.L. Miglioretti, and B.C. Yankaskas Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography Ann Intern Med 138 2003 168 175 (Pubitemid 36231622)
42. E.A. Sickles, D.L. Miglioretti, and R. Ballard-Barbash Performance benchmarks for diagnostic mammography Radiology 235 2005 775 790 (Pubitemid 40695870)
43. L. Liberman, T.L. Feng, D.D. Dershaw, E.A. Morris, and A.F. Abramson US-guided core breast biopsy: use and cost-effectiveness Radiology 208 1998 717 723 (Pubitemid 28405108)
44. A.J. Doyle, K.A. Murray, E.W. Nelson, and D.G. Bragg Selective use of image-guided large-core needle biopsy of the breast: accuracy and cost-effectiveness AJR Am J Roentgenol 165 1995 281 284
45. M. Sabel, and H. Aichinger Recent developments in breast imaging Phys Med Biol 41 1996 315 368 (Pubitemid 26098979)
46. D.A. Bluemke, C.A. Gatsonis, and M.H. Chen Magnetic resonance imaging of the breast prior to biopsy JAMA 292 2004 2735 2742 (Pubitemid 39628252)
47. E. Warner, D.B. Plewes, and K.A. Hill Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 2004 1317 1325 (Pubitemid 39223222)
48. R. Jiang, X. Liang, Q. Zhang, S. Grobmyer, L.L. Fajardo, and H. Jiang Phase-contrast diffuse optical tomography for in vivo breast imaging: a two-step method Appl Opt 48 2009 4749 4755
49. V. Ntziachristos, A.G. Yodh, M.D. Schnall, and B. Chance MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions Neoplasia 4 2002 347 354 (Pubitemid 34755845)
50. H. Jiang, Y. Xu, and N. Iftimia Three-dimensional optical tomographic imaging of breast in a human subject IEEE Trans Med Imaging 20 2001 1334 1340 (Pubitemid 34125142)
51. M.A. Franceschini, K.T. Moesta, and S. Fantini Frequency-domain techniques enhance optical mammography: initial clinical results Proc Natl Acad Sci U S A 94 1997 6468 6473 (Pubitemid 27270708)
52. D. Grosenick, K.T. Moesta, and H. Wabnitz Time-domain optical mammography: initial clinical results on detection and characterization of breast tumors Appl Opt 42 2003 3170 3186
53. D.R. Leff, O.J. Warren, and L.C. Enfield Diffuse optical imaging of the healthy and diseased breast: a systematic review Breast Cancer Res Treat 108 2008 9 22 (Pubitemid 351623242)
54. X. Liang, Q. Zhang, C. Li, S.R. Grobmyer, L.L. Fajardo, and H. Jiang Phase-contrast diffuse optical tomography pilot results in the breast Acad Radiol 15 2008 859 866 (Pubitemid 352033553)
55. V. Ntziachristos, A.G. Yodh, M. Schnall, and B. Chance Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement Proc Natl Acad Sci U S A 97 2000 2767 2772 (Pubitemid 30159246)
56. A. Corlu, R. Choe, and T. Durduran Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans Opt Express 15 2007 6696 6716 (Pubitemid 46827669)
57. R. Weissleder Molecular imaging in cancer Science 312 2006 1168 1171 (Pubitemid 43801133)
58. W.K. Moon, Y. Lin, and T. O'Loughlin Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate Bioconjug Chem 14 2003 539 545 (Pubitemid 36597363)
59. S. Ke, X. Wen, M. Gurfinkel, and C. Charnsangavej Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts Cancer Res 63 2003 7870 7875 (Pubitemid 37466721)
60. W. Wang, S. Ke, and Q. Wu Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts Mol Imaging 3 2004 343 351 (Pubitemid 40245456)
61. M. Funovics, X. Montet, F. Reynolds, R. Weissleder, and L. Josephson Nanoparticles for the optical imaging of tumor E-selectin Neoplasia 7 2005 904 911
62. L. Sampath, S. Kwon, and S. Ke Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer J Nucl Med 48 2007 1501 1510 (Pubitemid 47397400)
63. K.E. Adams, S. Ke, and S. Kwon Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer J Biomed Opt 12 2007 024017
64. Z. Cheng, Y. Wu, Z. Xiong, S.S. Gambhir, and X. Chen Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice Bioconjug Chem 16 2005 1433 1441 (Pubitemid 41681509)
65. U. Mahmood, C.H. Tung, Y. Tang, and R. Weissleder Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice Radiology 224 2002 446 451 (Pubitemid 34809126)
66. L. Yang, H. Mao, and Z. Cao Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles Gastroenterology 136 2009 1514 1525 e2
67. M.R. Lisy, A. Goermar, and C. Thomas In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice Radiology 247 2008 779 787
68. K. Kelly, H. Alencar, M. Funovics, U. Mahmood, and R. Weissleder Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide Cancer Res 64 2004 6247 6251 (Pubitemid 39129427)
69. L. Yang, H. Mao, and Y.A. Wang Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging Small 5 2009 235 243
70. S.B. Lee, M. Hassan, and R. Fisher Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging Clin Cancer Res 14 2008 3840 3849
71. U. Mahmood, C.H. Tung, A. Bogdanov Jr, and R. Weissleder Near-infrared optical imaging of protease activity for tumor detection Radiology 213 1999 866 870
72. C. Bremer, V. Ntziachristos, B. Weitkamp, G. Theilmeier, W. Heindel, and R. Weissleder Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes Invest Radiol 40 2005 321 327 (Pubitemid 40734559)
73. U. Mahmood, and R. Weissleder Near-infrared optical imaging of proteases in cancer Mol Cancer Ther 2 2003 489 496
74. R.K. Jain Antiangiogenic therapy for cancer: current and emerging concepts Oncology (Williston Park) 19 2005 7 16
75. T.C. Yih, and M. Al-Fandi Engineered nanoparticles as precise drug delivery systems J Cell Biochem 97 2006 1184 1190
76. S.D. Perrault, C. Walkey, T. Jennings, H.C. Fischer, and W.C. Chan Mediating tumor targeting efficiency of nanoparticles through design Nano Lett 9 2009 1909 1915
77. E.I. Altinoglu, T.J. Russin, and J.M. Kaiser Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer ACS Nano 2 2008 2075 2084
78. M.A. Yaseen, J. Yu, M.S. Wong, and B. Anvari Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy J Biomed Opt 12 2007 064031